nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—CHRND—Galantamine—Alzheimer's disease	0.176	0.219	CbGbCtD
Rocuronium—CHRNB1—Galantamine—Alzheimer's disease	0.176	0.219	CbGbCtD
Rocuronium—CHRNA1—Galantamine—Alzheimer's disease	0.176	0.219	CbGbCtD
Rocuronium—HTR3A—Memantine—Alzheimer's disease	0.145	0.181	CbGbCtD
Rocuronium—CHRNA2—Galantamine—Alzheimer's disease	0.13	0.162	CbGbCtD
Rocuronium—Respiratory insufficiency—Memantine—Alzheimer's disease	0.00577	0.0786	CcSEcCtD
Rocuronium—Respiratory insufficiency—Rivastigmine—Alzheimer's disease	0.00565	0.0769	CcSEcCtD
Rocuronium—Electrocardiogram abnormal—Donepezil—Alzheimer's disease	0.00293	0.0399	CcSEcCtD
Rocuronium—Electrocardiogram abnormal—Memantine—Alzheimer's disease	0.00266	0.0362	CcSEcCtD
Rocuronium—Electrocardiogram abnormal—Rivastigmine—Alzheimer's disease	0.0026	0.0354	CcSEcCtD
Rocuronium—Paralysis—Memantine—Alzheimer's disease	0.00251	0.0342	CcSEcCtD
Rocuronium—Hiccups—Galantamine—Alzheimer's disease	0.00248	0.0337	CcSEcCtD
Rocuronium—Apnoea—Memantine—Alzheimer's disease	0.00206	0.028	CcSEcCtD
Rocuronium—Apnoea—Rivastigmine—Alzheimer's disease	0.00201	0.0274	CcSEcCtD
Rocuronium—Cardiovascular disorder—Memantine—Alzheimer's disease	0.00198	0.027	CcSEcCtD
Rocuronium—Cardiovascular disorder—Rivastigmine—Alzheimer's disease	0.00194	0.0264	CcSEcCtD
Rocuronium—Wheezing—Donepezil—Alzheimer's disease	0.00186	0.0254	CcSEcCtD
Rocuronium—Respiratory failure—Memantine—Alzheimer's disease	0.00177	0.0242	CcSEcCtD
Rocuronium—Respiratory failure—Rivastigmine—Alzheimer's disease	0.00174	0.0236	CcSEcCtD
Rocuronium—Hiccups—Rivastigmine—Alzheimer's disease	0.00171	0.0232	CcSEcCtD
Rocuronium—CHRNA2—forebrain—Alzheimer's disease	0.00163	0.0769	CbGeAlD
Rocuronium—Muscular weakness—Galantamine—Alzheimer's disease	0.00159	0.0216	CcSEcCtD
Rocuronium—Pipecuronium—BCHE—Alzheimer's disease	0.00139	0.525	CrCbGaD
Rocuronium—Pancuronium—BCHE—Alzheimer's disease	0.00126	0.475	CrCbGaD
Rocuronium—Muscular weakness—Donepezil—Alzheimer's disease	0.00123	0.0167	CcSEcCtD
Rocuronium—Asthma—Donepezil—Alzheimer's disease	0.0012	0.0164	CcSEcCtD
Rocuronium—HTR3A—forebrain—Alzheimer's disease	0.00116	0.0549	CbGeAlD
Rocuronium—Muscular weakness—Memantine—Alzheimer's disease	0.00112	0.0152	CcSEcCtD
Rocuronium—Arrhythmia—Galantamine—Alzheimer's disease	0.00111	0.0151	CcSEcCtD
Rocuronium—Asthma—Memantine—Alzheimer's disease	0.00109	0.0149	CcSEcCtD
Rocuronium—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00109	0.0149	CcSEcCtD
Rocuronium—Bronchospasm—Memantine—Alzheimer's disease	0.00108	0.0146	CcSEcCtD
Rocuronium—HTR3A—telencephalon—Alzheimer's disease	0.00107	0.0505	CbGeAlD
Rocuronium—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00105	0.0143	CcSEcCtD
Rocuronium—CHRM2—forebrain—Alzheimer's disease	0.000972	0.0459	CbGeAlD
Rocuronium—SLC22A1—forebrain—Alzheimer's disease	0.000955	0.045	CbGeAlD
Rocuronium—Hypertension—Galantamine—Alzheimer's disease	0.000935	0.0127	CcSEcCtD
Rocuronium—SLCO1A2—forebrain—Alzheimer's disease	0.000919	0.0434	CbGeAlD
Rocuronium—CHRM2—telencephalon—Alzheimer's disease	0.000894	0.0422	CbGeAlD
Rocuronium—CHRNA2—nervous system—Alzheimer's disease	0.000885	0.0417	CbGeAlD
Rocuronium—SLC22A1—telencephalon—Alzheimer's disease	0.000878	0.0414	CbGeAlD
Rocuronium—Shock—Galantamine—Alzheimer's disease	0.000869	0.0118	CcSEcCtD
Rocuronium—Tachycardia—Galantamine—Alzheimer's disease	0.000862	0.0117	CcSEcCtD
Rocuronium—Arrhythmia—Donepezil—Alzheimer's disease	0.000861	0.0117	CcSEcCtD
Rocuronium—CHRNA2—central nervous system—Alzheimer's disease	0.000852	0.0402	CbGeAlD
Rocuronium—SLCO1A2—telencephalon—Alzheimer's disease	0.000845	0.0399	CbGeAlD
Rocuronium—CHRNA2—cerebellum—Alzheimer's disease	0.000832	0.0393	CbGeAlD
Rocuronium—Hypotension—Galantamine—Alzheimer's disease	0.000826	0.0112	CcSEcCtD
Rocuronium—CHRNA1—brain—Alzheimer's disease	0.000815	0.0384	CbGeAlD
Rocuronium—Arrhythmia—Memantine—Alzheimer's disease	0.000782	0.0106	CcSEcCtD
Rocuronium—CHRNB1—cerebellum—Alzheimer's disease	0.000775	0.0365	CbGeAlD
Rocuronium—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000765	0.0104	CcSEcCtD
Rocuronium—Hypertension—Donepezil—Alzheimer's disease	0.000724	0.00987	CcSEcCtD
Rocuronium—CHRNA2—brain—Alzheimer's disease	0.000676	0.0319	CbGeAlD
Rocuronium—Shock—Donepezil—Alzheimer's disease	0.000674	0.00918	CcSEcCtD
Rocuronium—Hypertension—Memantine—Alzheimer's disease	0.000658	0.00896	CcSEcCtD
Rocuronium—Hypersensitivity—Galantamine—Alzheimer's disease	0.000651	0.00887	CcSEcCtD
Rocuronium—Hypertension—Rivastigmine—Alzheimer's disease	0.000643	0.00876	CcSEcCtD
Rocuronium—Hypotension—Donepezil—Alzheimer's disease	0.00064	0.00872	CcSEcCtD
Rocuronium—HTR3A—nervous system—Alzheimer's disease	0.000632	0.0298	CbGeAlD
Rocuronium—CHRNB1—brain—Alzheimer's disease	0.000629	0.0297	CbGeAlD
Rocuronium—Shock—Memantine—Alzheimer's disease	0.000612	0.00833	CcSEcCtD
Rocuronium—HTR3A—central nervous system—Alzheimer's disease	0.000609	0.0287	CbGeAlD
Rocuronium—Tachycardia—Memantine—Alzheimer's disease	0.000607	0.00827	CcSEcCtD
Rocuronium—Shock—Rivastigmine—Alzheimer's disease	0.000598	0.00815	CcSEcCtD
Rocuronium—Tachycardia—Rivastigmine—Alzheimer's disease	0.000594	0.00809	CcSEcCtD
Rocuronium—Hypotension—Memantine—Alzheimer's disease	0.000581	0.00791	CcSEcCtD
Rocuronium—Hypotension—Rivastigmine—Alzheimer's disease	0.000568	0.00774	CcSEcCtD
Rocuronium—Vomiting—Galantamine—Alzheimer's disease	0.000562	0.00765	CcSEcCtD
Rocuronium—Rash—Galantamine—Alzheimer's disease	0.000557	0.00759	CcSEcCtD
Rocuronium—Dermatitis—Galantamine—Alzheimer's disease	0.000557	0.00758	CcSEcCtD
Rocuronium—CHRM2—nervous system—Alzheimer's disease	0.000528	0.0249	CbGeAlD
Rocuronium—Nausea—Galantamine—Alzheimer's disease	0.000525	0.00715	CcSEcCtD
Rocuronium—SLC22A1—nervous system—Alzheimer's disease	0.000518	0.0245	CbGeAlD
Rocuronium—CHRM2—central nervous system—Alzheimer's disease	0.000508	0.024	CbGeAlD
Rocuronium—Hypersensitivity—Donepezil—Alzheimer's disease	0.000505	0.00687	CcSEcCtD
Rocuronium—SLCO1A2—nervous system—Alzheimer's disease	0.000499	0.0235	CbGeAlD
Rocuronium—SLC22A1—central nervous system—Alzheimer's disease	0.000499	0.0235	CbGeAlD
Rocuronium—Pruritus—Donepezil—Alzheimer's disease	0.000485	0.0066	CcSEcCtD
Rocuronium—HTR3A—brain—Alzheimer's disease	0.000483	0.0228	CbGeAlD
Rocuronium—SLCO1A2—central nervous system—Alzheimer's disease	0.00048	0.0227	CbGeAlD
Rocuronium—SLCO1A2—cerebellum—Alzheimer's disease	0.00047	0.0222	CbGeAlD
Rocuronium—Hypersensitivity—Memantine—Alzheimer's disease	0.000458	0.00624	CcSEcCtD
Rocuronium—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000448	0.0061	CcSEcCtD
Rocuronium—Pruritus—Memantine—Alzheimer's disease	0.00044	0.00599	CcSEcCtD
Rocuronium—Vomiting—Donepezil—Alzheimer's disease	0.000435	0.00593	CcSEcCtD
Rocuronium—Rash—Donepezil—Alzheimer's disease	0.000432	0.00588	CcSEcCtD
Rocuronium—Dermatitis—Donepezil—Alzheimer's disease	0.000431	0.00588	CcSEcCtD
Rocuronium—Pruritus—Rivastigmine—Alzheimer's disease	0.00043	0.00586	CcSEcCtD
Rocuronium—Nausea—Donepezil—Alzheimer's disease	0.000407	0.00554	CcSEcCtD
Rocuronium—CHRM2—brain—Alzheimer's disease	0.000403	0.019	CbGeAlD
Rocuronium—SLC22A1—brain—Alzheimer's disease	0.000396	0.0187	CbGeAlD
Rocuronium—Vomiting—Memantine—Alzheimer's disease	0.000395	0.00538	CcSEcCtD
Rocuronium—Rash—Memantine—Alzheimer's disease	0.000392	0.00534	CcSEcCtD
Rocuronium—Dermatitis—Memantine—Alzheimer's disease	0.000392	0.00533	CcSEcCtD
Rocuronium—Vomiting—Rivastigmine—Alzheimer's disease	0.000387	0.00527	CcSEcCtD
Rocuronium—Rash—Rivastigmine—Alzheimer's disease	0.000384	0.00522	CcSEcCtD
Rocuronium—Dermatitis—Rivastigmine—Alzheimer's disease	0.000383	0.00522	CcSEcCtD
Rocuronium—SLCO1A2—brain—Alzheimer's disease	0.000381	0.018	CbGeAlD
Rocuronium—Nausea—Memantine—Alzheimer's disease	0.000369	0.00503	CcSEcCtD
Rocuronium—Nausea—Rivastigmine—Alzheimer's disease	0.000361	0.00492	CcSEcCtD
Rocuronium—CHRND—Neuronal System—CREB1—Alzheimer's disease	6.87e-05	0.000688	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—CALM1—Alzheimer's disease	6.82e-05	0.000683	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—PYY—Alzheimer's disease	6.77e-05	0.000678	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	6.55e-05	0.000656	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—GRIA1—Alzheimer's disease	6.51e-05	0.000652	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—CALM1—Alzheimer's disease	6.48e-05	0.000649	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	6.44e-05	0.000645	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	6.32e-05	0.000633	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	6.28e-05	0.000629	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—CHRNB2—Alzheimer's disease	6.16e-05	0.000617	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	6.16e-05	0.000617	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	6.14e-05	0.000615	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—NPY—Alzheimer's disease	6.09e-05	0.00061	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	6.07e-05	0.000608	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—DHCR24—Alzheimer's disease	6.06e-05	0.000607	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—CREB1—Alzheimer's disease	5.84e-05	0.000585	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	5.66e-05	0.000567	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—ACHE—Alzheimer's disease	5.66e-05	0.000567	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5.65e-05	0.000566	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR6—Alzheimer's disease	5.65e-05	0.000566	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—CHRNA4—Alzheimer's disease	5.6e-05	0.000561	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	5.57e-05	0.000558	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—CREB1—Alzheimer's disease	5.55e-05	0.000556	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	5.5e-05	0.000551	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	5.42e-05	0.000543	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—SST—Alzheimer's disease	5.31e-05	0.000532	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	5.28e-05	0.000529	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	5.2e-05	0.000521	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—APP—Alzheimer's disease	5.18e-05	0.000518	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.16e-05	0.000517	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CA4—Alzheimer's disease	5.15e-05	0.000516	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	5.11e-05	0.000512	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	5.04e-05	0.000505	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—BCHE—Alzheimer's disease	4.93e-05	0.000494	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	4.88e-05	0.000489	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GAPDHS—Alzheimer's disease	4.85e-05	0.000485	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	4.84e-05	0.000485	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—DLG4—Alzheimer's disease	4.81e-05	0.000482	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—CP—Alzheimer's disease	4.79e-05	0.00048	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—GRIN2B—Alzheimer's disease	4.7e-05	0.000471	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—GAL—Alzheimer's disease	4.69e-05	0.00047	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—PLCB1—Alzheimer's disease	4.65e-05	0.000466	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	4.65e-05	0.000466	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ATP5A1—Alzheimer's disease	4.59e-05	0.00046	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	4.5e-05	0.000451	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	4.49e-05	0.00045	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—DHCR24—Alzheimer's disease	4.43e-05	0.000444	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	4.43e-05	0.000443	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PLD3—Alzheimer's disease	4.38e-05	0.000439	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.38e-05	0.000439	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	4.37e-05	0.000438	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.33e-05	0.000434	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—F2—Alzheimer's disease	4.23e-05	0.000423	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	4.22e-05	0.000423	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HSD17B10—Alzheimer's disease	4.2e-05	0.000421	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	4.11e-05	0.000412	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.11e-05	0.000411	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—TF—Alzheimer's disease	4.07e-05	0.000408	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP46A1—Alzheimer's disease	4.04e-05	0.000405	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ND1—Alzheimer's disease	3.91e-05	0.000391	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	3.89e-05	0.000389	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PYY—Alzheimer's disease	3.82e-05	0.000383	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.82e-05	0.000382	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CA4—Alzheimer's disease	3.76e-05	0.000377	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	3.71e-05	0.000372	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—NPY—Alzheimer's disease	3.69e-05	0.000369	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—IAPP—Alzheimer's disease	3.66e-05	0.000367	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CRH—Alzheimer's disease	3.56e-05	0.000356	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GAPDHS—Alzheimer's disease	3.54e-05	0.000355	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—CP—Alzheimer's disease	3.5e-05	0.00035	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.49e-05	0.00035	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PYY—Alzheimer's disease	3.47e-05	0.000348	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—PRKCG—Alzheimer's disease	3.44e-05	0.000345	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—CCR5—Alzheimer's disease	3.42e-05	0.000343	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—NPS—Alzheimer's disease	3.37e-05	0.000338	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ATP5A1—Alzheimer's disease	3.36e-05	0.000336	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	3.33e-05	0.000333	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—SST—Alzheimer's disease	3.22e-05	0.000322	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PLD3—Alzheimer's disease	3.2e-05	0.000321	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR6—Alzheimer's disease	3.19e-05	0.00032	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	3.18e-05	0.000318	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—APP—Alzheimer's disease	3.13e-05	0.000314	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	3.11e-05	0.000311	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HSD17B10—Alzheimer's disease	3.07e-05	0.000307	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CDK5—Alzheimer's disease	3.01e-05	0.000302	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.01e-05	0.000302	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—CALM1—Alzheimer's disease	2.98e-05	0.000298	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—TF—Alzheimer's disease	2.97e-05	0.000298	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP46A1—Alzheimer's disease	2.95e-05	0.000296	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR6—Alzheimer's disease	2.9e-05	0.00029	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ND1—Alzheimer's disease	2.85e-05	0.000286	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.85e-05	0.000285	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	2.75e-05	0.000276	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	2.75e-05	0.000275	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.74e-05	0.000274	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	2.72e-05	0.000273	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	2.66e-05	0.000267	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GAL—Alzheimer's disease	2.65e-05	0.000266	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—CREB1—Alzheimer's disease	2.55e-05	0.000255	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CHAT—Alzheimer's disease	2.52e-05	0.000252	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TPI1—Alzheimer's disease	2.52e-05	0.000252	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MAOB—Alzheimer's disease	2.41e-05	0.000242	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GAL—Alzheimer's disease	2.41e-05	0.000241	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TTR—Alzheimer's disease	2.35e-05	0.000235	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	2.33e-05	0.000234	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	2.33e-05	0.000234	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GAPDH—Alzheimer's disease	2.32e-05	0.000233	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.3e-05	0.00023	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.28e-05	0.000228	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—A2M—Alzheimer's disease	2.24e-05	0.000225	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—NPY—Alzheimer's disease	2.08e-05	0.000209	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.08e-05	0.000208	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.08e-05	0.000208	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CCR5—Alzheimer's disease	2.07e-05	0.000208	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—IAPP—Alzheimer's disease	2.07e-05	0.000207	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PYY—Alzheimer's disease	2.05e-05	0.000206	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR2A—Alzheimer's disease	2.03e-05	0.000203	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CRH—Alzheimer's disease	2.01e-05	0.000201	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2e-05	0.0002	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2e-05	0.0002	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ACHE—Alzheimer's disease	1.95e-05	0.000196	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—INPP5D—Alzheimer's disease	1.93e-05	0.000193	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—NPS—Alzheimer's disease	1.9e-05	0.000191	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—NPY—Alzheimer's disease	1.89e-05	0.000189	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IAPP—Alzheimer's disease	1.88e-05	0.000188	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CHAT—Alzheimer's disease	1.84e-05	0.000184	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TPI1—Alzheimer's disease	1.84e-05	0.000184	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ENO1—Alzheimer's disease	1.83e-05	0.000183	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTGS1—Alzheimer's disease	1.83e-05	0.000183	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CRH—Alzheimer's disease	1.82e-05	0.000183	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GAB2—Alzheimer's disease	1.82e-05	0.000182	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—SST—Alzheimer's disease	1.82e-05	0.000182	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP2D6—Alzheimer's disease	1.79e-05	0.00018	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	1.78e-05	0.000178	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	1.78e-05	0.000178	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	1.77e-05	0.000177	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MAOB—Alzheimer's disease	1.76e-05	0.000177	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	1.73e-05	0.000173	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.72e-05	0.000172	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	1.71e-05	0.000172	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—BCHE—Alzheimer's disease	1.7e-05	0.00017	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GAPDH—Alzheimer's disease	1.7e-05	0.00017	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.67e-05	0.000167	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	1.65e-05	0.000165	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	1.65e-05	0.000165	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—A2M—Alzheimer's disease	1.64e-05	0.000164	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.61e-05	0.000162	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	1.61e-05	0.000161	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PLCB1—Alzheimer's disease	1.6e-05	0.000161	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	1.58e-05	0.000159	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.57e-05	0.000158	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ABCA1—Alzheimer's disease	1.56e-05	0.000156	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	1.55e-05	0.000156	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	1.53e-05	0.000154	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	1.52e-05	0.000152	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	1.49e-05	0.00015	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	1.46e-05	0.000146	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ACHE—Alzheimer's disease	1.43e-05	0.000143	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	1.42e-05	0.000142	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	1.42e-05	0.000142	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—INPP5D—Alzheimer's disease	1.41e-05	0.000141	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.34e-05	0.000134	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ENO1—Alzheimer's disease	1.34e-05	0.000134	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS1—Alzheimer's disease	1.34e-05	0.000134	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HMOX1—Alzheimer's disease	1.33e-05	0.000134	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2D6—Alzheimer's disease	1.31e-05	0.000131	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	1.25e-05	0.000126	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—BCHE—Alzheimer's disease	1.24e-05	0.000124	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.24e-05	0.000124	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—LPL—Alzheimer's disease	1.22e-05	0.000122	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	1.21e-05	0.000122	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PLCB1—Alzheimer's disease	1.17e-05	0.000117	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.17e-05	0.000117	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.15e-05	0.000115	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCA1—Alzheimer's disease	1.14e-05	0.000114	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.12e-05	0.000112	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	1.12e-05	0.000112	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	1.11e-05	0.000111	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MTHFR—Alzheimer's disease	1.1e-05	0.00011	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	1.08e-05	0.000108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	1.06e-05	0.000107	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.04e-05	0.000104	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CALM1—Alzheimer's disease	1.03e-05	0.000103	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—APOE—Alzheimer's disease	1.02e-05	0.000102	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	1.02e-05	0.000102	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.02e-05	0.000102	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CAV1—Alzheimer's disease	1.01e-05	0.000102	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	1e-05	0.000101	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	1e-05	0.0001	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PPARGC1A—Alzheimer's disease	9.79e-06	9.81e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SST—Alzheimer's disease	9.75e-06	9.76e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	9.75e-06	9.76e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	9.75e-06	9.76e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HMOX1—Alzheimer's disease	9.74e-06	9.76e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	9.71e-06	9.73e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	9.66e-06	9.68e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APP—Alzheimer's disease	9.5e-06	9.52e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	9.12e-06	9.14e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	8.96e-06	8.98e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—LPL—Alzheimer's disease	8.91e-06	8.93e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PPARG—Alzheimer's disease	8.91e-06	8.93e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—INS—Alzheimer's disease	8.74e-06	8.75e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	8.36e-06	8.38e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	8.31e-06	8.33e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	8.17e-06	8.18e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	8.13e-06	8.15e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTHFR—Alzheimer's disease	8.02e-06	8.04e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	7.72e-06	7.74e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NOS3—Alzheimer's disease	7.66e-06	7.68e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CALM1—Alzheimer's disease	7.5e-06	7.51e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—APOE—Alzheimer's disease	7.47e-06	7.48e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CAV1—Alzheimer's disease	7.4e-06	7.42e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	7.35e-06	7.37e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	7.11e-06	7.12e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTGS2—Alzheimer's disease	7.01e-06	7.02e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	6.82e-06	6.83e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	6.76e-06	6.77e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	6.63e-06	6.64e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PPARG—Alzheimer's disease	6.51e-06	6.52e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	6.46e-06	6.47e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—INS—Alzheimer's disease	6.38e-06	6.39e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	6.28e-06	6.29e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	6.15e-06	6.16e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	5.73e-06	5.74e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	5.71e-06	5.72e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	5.71e-06	5.72e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	5.66e-06	5.67e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NOS3—Alzheimer's disease	5.6e-06	5.61e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	5.46e-06	5.47e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—F2—Alzheimer's disease	5.39e-06	5.4e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	5.27e-06	5.28e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	5.12e-06	5.13e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	4.95e-06	4.96e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	4.91e-06	4.92e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—INS—Alzheimer's disease	4.88e-06	4.89e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	4.8e-06	4.81e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	4.72e-06	4.73e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	4.28e-06	4.29e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.67e-06	3.68e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	3.63e-06	3.64e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	3.61e-06	3.62e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKT1—Alzheimer's disease	3.52e-06	3.53e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	3.34e-06	3.35e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	3.33e-06	3.34e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	3.08e-06	3.09e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	2.83e-06	2.84e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKT1—Alzheimer's disease	2.57e-06	2.58e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	2.33e-06	2.33e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	2.13e-06	2.14e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.97e-06	1.97e-05	CbGpPWpGaD
